| Product Code: ETC9560630 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Non-Small Cell Lung Cancer Therapeutics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Non-Small Cell Lung Cancer Therapeutics Market - Industry Life Cycle |
3.4 Sweden Non-Small Cell Lung Cancer Therapeutics Market - Porter's Five Forces |
3.5 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
4 Sweden Non-Small Cell Lung Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Sweden |
4.2.2 Advancements in targeted therapy and immunotherapy options for non-small cell lung cancer |
4.2.3 Growing investments in research and development for innovative treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in Sweden |
4.3.2 High cost associated with novel therapeutics for non-small cell lung cancer |
4.3.3 Limited accessibility to advanced treatment options in certain regions of Sweden |
5 Sweden Non-Small Cell Lung Cancer Therapeutics Market Trends |
6 Sweden Non-Small Cell Lung Cancer Therapeutics Market, By Types |
6.1 Sweden Non-Small Cell Lung Cancer Therapeutics Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.4 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.5 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.5 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Non-Small Cell Lung Cancer Therapeutics Market, By Cancer Type |
6.3.1 Overview and Analysis |
6.3.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.3.3 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Squamous cell carcinoma, 2021- 2031F |
6.3.4 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Large cell carcinoma, 2021- 2031F |
7 Sweden Non-Small Cell Lung Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 Sweden Non-Small Cell Lung Cancer Therapeutics Market Export to Major Countries |
7.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market Imports from Major Countries |
8 Sweden Non-Small Cell Lung Cancer Therapeutics Market Key Performance Indicators |
8.1 Average survival rate of patients receiving new therapeutics |
8.2 Adoption rate of targeted therapy and immunotherapy in non-small cell lung cancer treatment |
8.3 Number of clinical trials conducted for non-small cell lung cancer therapeutics in Sweden |
9 Sweden Non-Small Cell Lung Cancer Therapeutics Market - Opportunity Assessment |
9.1 Sweden Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Sweden Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10 Sweden Non-Small Cell Lung Cancer Therapeutics Market - Competitive Landscape |
10.1 Sweden Non-Small Cell Lung Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Non-Small Cell Lung Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here